Literature DB >> 1563101

Effects of C4 null alleles and homoduplications on quantitative expression of C4A and C4B.

A Hammond1, W Ollier, M J Walport.   

Abstract

The availability of MoAbs now allows the accurate quantification of the individual C4 isotypes, C4A and C4B. Using a sensitive two-site immunoradiometric technique to measure serum levels of C4A and C4B, we studied the relationship between genotype and phenotype and physiological factors affecting C4 expression in 129 fully genotyped healthy subjects. Our results confirm that there is extensive phenotypic overlap between genotypic groups and it was not possible to determine the presence of single null alleles from total serum C4. Of the factors which may influence C4 expression, we found that age contributes a very small influence but that gender has no effect and there was no evidence for the presence of feedback of null alleles on the expression of remaining genes. Potential problems in quantifying C4 arising from the complex relationship between isotypic identity and serotypic recognition were highlighted by the finding of reversed antigenic expression of a C4B*5 molecule which was recognized as C4A by the anti-Rg:1 monoclonal used in these studies. We also confirmed that the extended MHC haplotype associated with Felty's syndrome, HLA-B44, C4A*3, C4BQ*O, HLA-DR4, encodes an expressed, duplicated, C4A gene.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1563101      PMCID: PMC1554358          DOI: 10.1111/j.1365-2249.1992.tb03057.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  31 in total

1.  A novel immunoassay for the quantitation of human C4 gene products.

Authors:  J M Moulds; F C Arnett; C G Giles; R G Hamilton
Journal:  Complement Inflamm       Date:  1990

2.  Regulation of expression of mouse C4 and Slp genes by non-H-2-linked genes.

Authors:  S M Bruisten; P Demant
Journal:  Immunogenetics       Date:  1989       Impact factor: 2.846

3.  Quantitative variation of C4 variant proteins associated with many MHC haplotypes.

Authors:  L Truedsson; Z Awdeh; E J Yunis; S Mrose; B Moore; C A Alper
Journal:  Immunogenetics       Date:  1989       Impact factor: 2.846

4.  Antigenic determinants expressed by human C4 allotypes; a study of 325 families provides evidence for the structural antigenic model.

Authors:  C M Giles; B Uring-Lambert; J Goetz; G Hauptmann; A H Fielder; W Ollier; C Rittner; T Robson
Journal:  Immunogenetics       Date:  1988       Impact factor: 2.846

Review 5.  A structural model for the location of the Rodgers and the Chido antigenic determinants and their correlation with the human complement component C4A/C4B isotypes.

Authors:  C Y Yu; R D Campbell; R R Porter
Journal:  Immunogenetics       Date:  1988       Impact factor: 2.846

6.  Genetic analysis of C4 deficiency.

Authors:  Z L Awdeh; H D Ochs; C A Alper
Journal:  J Clin Invest       Date:  1981-01       Impact factor: 14.808

7.  C4 concentrations and C4 deficiency alleles in systemic lupus erythematosus.

Authors:  W A Wilson; P E Armatis; M C Perez
Journal:  Ann Rheum Dis       Date:  1989-07       Impact factor: 19.103

8.  Reduced numbers of complement receptor type 1 on erythrocytes are associated with increased levels of anticardiolipin antibodies. Findings in patients with systemic lupus erythematosus and the antiphospholipid syndrome.

Authors:  A Hammond; A C Rudge; S Loizou; S J Bowcock; M J Walport
Journal:  Arthritis Rheum       Date:  1989-03

9.  Definitive RFLPs to distinguish between the human complement C4A/C4B isotypes and the major Rodgers/Chido determinants: application to the study of C4 null alleles.

Authors:  C Y Yu; R D Campbell
Journal:  Immunogenetics       Date:  1987       Impact factor: 2.846

10.  Direct observation of the gene organization of the complement C4 and 21-hydroxylase loci by pulsed field gel electrophoresis.

Authors:  I Dunham; C A Sargent; R L Dawkins; R D Campbell
Journal:  J Exp Med       Date:  1989-05-01       Impact factor: 14.307

View more
  5 in total

1.  Lack of evidence of a specific role for C4A gene deficiency in determining disease susceptibility among C4-deficient patients with systemic lupus erythematosus (SLE).

Authors:  M A Dragon-Durey; N Rougier; J P Clauvel; S Caillat-Zucman; P Remy; L Guillevin; F Liote; J Blouin; F Ariey; B U Lambert; M D Kazatchkine; L Weiss
Journal:  Clin Exp Immunol       Date:  2001-01       Impact factor: 4.330

2.  Serum C4 concentration and risk of atherosclerosis.

Authors:  L A Moreno; A Sarria; A Lazaro; M Bueno; L Larrad
Journal:  BMJ       Date:  1994-10-22

3.  DNase I hypersensitivity mapping and promoter polymorphism analysis of human C4.

Authors:  A K Vaishnaw; R Hargreaves; R D Campbell; B J Morley; M J Walport
Journal:  Immunogenetics       Date:  1995       Impact factor: 2.846

4.  Measurement in saliva from neurotypical adults of biomarkers pertinent to autism spectrum disorders.

Authors:  Helen V Ratajczak; Robert B Sothern
Journal:  Future Sci OA       Date:  2015-11-01

5.  Low copy numbers of complement C4 and homozygous deficiency of C4A may predispose to severe disease and earlier disease onset in patients with systemic lupus erythematosus.

Authors:  M Jüptner; F Flachsbart; A Caliebe; W Lieb; S Schreiber; R Zeuner; A Franke; J O Schröder
Journal:  Lupus       Date:  2017-10-19       Impact factor: 2.911

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.